We find strong positive relationships between gill slit height and gill surface area at two scales (i) for total gill surface area and mean gill slit height across species and (ii) for parabranchial gill surface area and individual gill slit height within and across species. We also find that gill slit height is a consistent proportion of the fork length of physical specimens. Consequently, relative gill slit height measured from field guide illustrations proved to be surprisingly comparable to those measured from physical specimens. While the generality of our findings needs to be evaluated across a wider range of taxonomy and ecological lifestyles, they offer the opportunity that we might only need to go to the library and measure field guide illustrations to yield a non-lethal, first-order approximation of the respiratory physiology of sharks.Light pollution is a rapidly growing threat to biodiversity, with many unknown or poorly understood effects on species and ecosystems spanning terrestrial and aquatic environments. Relative to other taxa, the effects of artificial light at night on aquatic invertebrates are poorly understood, despite the abundance and integral significance of invertebrates to marine and freshwater ecosystems. We affixed heart rate and acceleration biologgers to adult Caribbean spiny lobster (Panulirus argus), an ecologically, culturally and economically significant species in the western Atlantic ocean, to test the effect of artificial light at night on this species' physiology and behaviour relative to appropriate controls. The experiment was conducted in a simulated reef mesocosm in The Bahamas with incandescent lighting used to illuminate it at 1 lux, approximating light levels offshore of urban areas. In the conditions tested here, artificial light at night was found to have no effect on heart rate or locomotor activity in P. argus. We observed a dissociation between activity and heart rate at both short-term and long-term temporal scales. Lobsters were more active at night and nocturnal activity was higher in trials closer to new moon; however, heart rate did not vary with diel or lunar cycle. There was less than 8% difference between daytime and night time average heart rate despite the average percentage of time spent active almost tripling in nights versus days, to 19.5% from 7.2%, respectively. Our findings suggest P. argus may have some resilience to low levels of light pollution, which warrants further research on aspects of this species' life history, performance and fitness in the face of this potential anthropogenic disturbance.Health assessments of wildlife species are becoming increasingly important in an ever-changing environment. Kemp's ridley sea turtles (Lepidochelys kempii; hereafter, Kemp's ridleys) are critically endangered and incur several on-going threats to their population recovery; therefore, it is imperative to advance the understanding of baseline blood analyte data as a diagnostic and monitoring tool. For in-water, trawl-captured, immature Kemp's ridleys (minimum Nā€‰=ā€‰31) from Georgia, USA, the objectives of this study were to (1) establish reference intervals (RIs) for packed cell volume (PCV) and 27 plasma biochemistry analytes and (2) determine length-specific relationships in blood analytes. We observed significant positive correlations between minimum straight carapace length and PCV, amylase, calciumphosphorus ratio, cholesterol, magnesium, triglycerides, total solids, total protein and all protein fractions (e.g. alpha-, beta- and gamma-globulins); aspartate aminotransferase and chloride showed significant negative relationships. These results suggest that certain blood analytes in Kemp's ridleys change as these animals grow, presumptively due to somatic growth and dietary shifts. The information presented herein, in due consideration of capture technique that may have impacted glucose and potassium concentrations, represents the first report of blood analyte RIs for Kemp's ridley sea turtles established by guidelines of the American Society for Veterinary Clinical Pathology and will have direct applications for stranded individuals in rehabilitative care and for future investigations into the health status of wild individuals from this population. COVID-19 can lead to a hyperinflammatory state. CD6 is a glycoprotein expressed on mature T lymphocytes which is a crucial regulator of the T-cell activation. Itolizumab is a humanised antibody targeting CD6. Nonclinical and clinical data in autoimmune diseases indicate that it lowers multiple cytokines primarily involving the Th1/Th17 pathway. The primary objective of this study was to assess the impact of itolizumab in arresting the lung function deterioration of COVID-19 patients. Secondary objectives included safety, duration of ventilation, 14-day mortality and evaluation of interleukin 6 concentration. Patients with confirmed SARS-CoV-2 received itolizumab in combination with other therapies included in the national protocol for COVID-19. Seventy critical, severe or moderate patients were treated with itolizumab in 10 Cuban hospitals. Median age was 68, and 94% had comorbidities. After 72h, most patients improved the PO /FiO ratio and reduced FiO2 requirements. Ventilation time was 8days for critical and 1day for severe cases. https://www.selleckchem.com/products/Nutlin-3.html Ten patients had related adverse events while 3 subjects developed related serious events. In 30 patients, interleukin 6 decreased in individuals with high level and did not change in those with lower concentration. Fourteen-day lethality rate was 4% and 18% for moderate and severe patients, respectively. The proportion of moderate or severe patients with ventilation or death at day 14 was 9.8%. Time to treatment, neurological manifestations and biomarkers such as NLR were significantly associated with higher lethality. The opportune administration of itolizumab might interrupt the hyperinflammatory cascade and prevent COVID-19 morbidity and mortality. The opportune administration of itolizumab might interrupt the hyperinflammatory cascade and prevent COVID-19 morbidity and mortality.